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Background: The aim of the present study is to investigate the responder rate of Electroconvulsive therapy, ECT,
in clinical routine work and to define clinical characteristics predictive of response to ECT. The main hypothesis is
that the responder rate of ECT might be lower in clinical routine than in controlled trials.
Methods: This is a population-based study of all patients (N = 990) treated with ECT for depressive disorders,
between 2008–2010 in eight hospitals in Sweden. Patients with Clinical Global Impression-Improvement scores of
1 or 2 (much improved) within one week after ECT were considered responders to ECT. The predictive values of
single clinical variables were tested by means of chi-squared tests and the relative importance was tested in a
logistic regression analysis.
Results: The responder rate was 80.1%. A higher proportion of older patients (>50 years) responded (84.3% vs.
74.2%, p < 0.001). Psychotically depressed patients responded better (88.9% vs. 81.5% for severely depressed and
72.8% for mildly depressed, p < 0.001). There were no significant differences in responder rates between patients
suffering from bipolar, first or recurrent major depressive syndromes, or a depressive episode of schizoaffective
disorder. Patients with personality disorder had a lower responder rate (66.2% vs. 81.4%, p < 0.001). Also, outpatients
had a lower responder rate (66.3%) compared to inpatients (83.4%, p < 0.001). In the logistic regression analysis,
inpatient status, psychotic symptoms, absence of schizoaffective disorder and older age were independent factors
associated with response to ECT.
Conclusions: This study focuses exclusively on the short term responder rate with ECT in clinical practice.
Similarly to results from controlled trials a high responder rate is reported. Older patients, more severely ill patients,
psychotically ill patients and patients without personality disorders had the highest responder rates. Inpatients
may have better outcome with ECT than outpatients.
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Electroconvulsive therapy, ECT, is an effective treatment
for severe forms of depression, such as psychotic or
catatonic depression. ECT has also been recommended
in less severe forms of depression after pharmacothera-
peutic failure [1]. The efficacy of ECT in severe depres-
sion is demonstrated to be high in clinical trials with* Correspondence: axel.nordenskjold@orebroll.se
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[2-4].
There may be a gap between the convincing results of
ECT achieved in clinical trials and the effectiveness in
clinical practice. In an earlier study by Prudic et al. con-
ducted in routinely treated patients, the response rate was
64% and the remission rate was only 30-47%, depending
on criteria [5]. One explanation for the gap may be
patient selection. Patients with co morbidities are often
excluded from clinical trials. If such patients are less likely
to benefit from ECT, it may contribute to the divergence.
The ultimate aim of treatment for depression is to
achieve remission of symptoms and restored socialentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Nordenskjöld et al. BMC Psychiatry 2012, 12:115 Page 2 of 7
http://www.biomedcentral.com/1471-244X/12/115functioning. However, symptoms from depression most
often abate gradually, and a response to treatment is an
important first goal.
Presence of psychotic symptoms[3,6], lower degree of
prior treatment resistance [7-9] and shorter symptom
duration [8,10] are relatively well established predictors
of response to ECT [11]. In addition, the CORE group
reported depression in old age to be associated with a
favorable outcome [12]. In a study from Finland,
younger patients suffering from moderate depression
and with co- morbidity had a lower responder rate as
compared to severely depressed older patients without
co-morbidity [13]. However, there are variations in
the results and the importances of several factors are
debated. In particular the importance of psychotic
depression [7,14] and greater initial severity [15] have
been questioned. Thus, more data is needed on the
importance of predictors of response to ECT.
The aim of the present study is to investigate the
responder rate of Electroconvulsive therapy, ECT, in
clinical routine work and to define clinical characteris-
tics predictive of response to ECT. The main hypothesis
is that the responder rate of ECT might be lower in clin-
ical routine than in controlled trials.
Methods
Subjects
In this study, 990 patients treated with ECT for major
depression or schizoaffective disorder, depressed type
between January 1, 2008 and December 31, 2010 in eight
hospitals in the middle of Sweden were identified. Infor-
mation about the clinical outcome was available for 936
patients. Our data therefore illustrate a population-based
cohort treated in ordinary clinical routine.
Inclusion criteria in the study were:
1) Diagnosis of Depressive Episode (F32), Major
Depressive Disorder (F33) Bipolar Disorder,
depressive episode (F31.3-F31.5) or Schizoaffective
disorder, depressive type (F25.1).
2) Treatment with ECT in one of the eight hospitals in
the middle of Sweden between January 1, 2008 and
December 31, 2010. Each patient was included only
with the first treatment series in the period.
Exclusion criteria from statistical analysis was:
1) No Clinical Global Impression – Improvement
(CGI-I) data available after ECT.
Included and excluded subjects
Out of 990 patients treated with ECT during the period,
54 patients were excluded from the response analysis
because no CGI-I data were available after ECT. Patients
with and without CGI-I ratings after ECT were similaras concerns age 54 years (SD 18) vs 53 (SD 16), sex
(57% vs 61% women), diagnoses (76% vs 79% unipolar
depression, 19% vs 17% bipolar depression and 5% vs 4%
schizoaffective disorder depressed type). The severity
of depression among patients with and without CGI-I
ratings were mild/moderate 32% vs 37%, severe without
psychosis 47% vs 44% and severe with psychosis 25% vs
16%. The proportion of diagnosed co-morbid personality
disorders were 8% among CGI-I rated patients vs 11%
for patients without CGI-I rating. 19% of the patients
with CGI-I ratings were outpatients vs 28% for patients
without the ratings. The number of ECT sessions given
for patients with CGI-I ratings was 8.0 (SD 3.2) vs. 7.2
(SD 3.7) for patients not rated.
The Quality register
The data in this study were derived from the Quality
register for ECT. Nurses at each site collected informa-
tion from the patients’ charts. In Sweden, all ECTs are
provided in psychiatric hospitals responsible for the
treatment of all patients in a defined geographical area.
Eight hospitals in the middle of Sweden collaborated in
2008–2010 to report clinical data to the register. The
eight hospitals cover a population of 1.5 million inhabi-
tants. Six hospitals started reporting data in 2008, one
hospital started in 2009 and one hospital in 2010.
Ethics
The Regional Ethical Vetting Board in Uppsala approved
the study. The patients were informed about the register
and accepted registration.
ECT-treatment
ECT was administered using a bidirectional constant
current, brief pulse device. The Mecta Spectrum 5000Q
device (Mecta Corp, Lake Oswego, Ore) was used at six
hospitals and a Thymatron system IV and a Thymatron
DGX device (Somatics, Inc, Lake Bluff, Ill) was used at
one hospital each.
Most treatments were unilateral, but in 13% at least
one of the treatments in the series was bitemporal and
in 4.8% at least one treatment was bifrontal. The mean
dosage at the last treatment if unilateral was 0.49 ms
(SD 0.14), 73 Hz (SD 23), 7.4 s (SD 0.83), 840 (SD 53)
mA and 451 (SD 186) mC. The mean number of ECT
sessions was 8.0 (SD 3.2).
Propofol (mean dosage 107 mg (SD 41) or thiopental
(mean dosage 306 mg (SD 98)) was used as anaesthetic.
Succinylcholine (1 mg/kg) was used as muscle relaxant
and glycopyrrolate (0.2 mg) was used as anticholinergic.
If no adverse events occurred, ECT was continued until
the patients were asymptomatic or the physician judged
that the patient had benefitted as much as possible.
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The pharmacotherapy was assessed at the conclusion of
the ECT series. An antidepressant drug was used by 87%
of the patients. Selective Serotonin Reuptake Inhibitors
were used by 36% of the patients, Serotonin–norepin-
ephrine reuptake inhibitors by 22%, mirtazapine by 25%,
tricyclics by 7%, other antidepressants by 19%, lithium
by 16%, lamotrigine by 10%, valproate by 3%, benzodia-
zepines by 24%, other antiepileptic drugs by 9% and anti-
psychotics by 39%. Specific psychotherapy was seldom
used but supportive care was provided. The supportive
care was more intensive for inpatients.
Variables and measures
The Clinical Global Impression – Improvement scale
(CGI-I) [16] is a scale ranging from 1= very much
improved, 2 =much improved, 3 =minimally improved
and 4 = not improved. Experienced nurses who met the
patients during the ECT sessions made the ratings. The
CGI-I rating was performed within one week after ECT.
When the nurses made the ratings, they had access to
the charts including the doctors’ professional assess-
ments and the patients’ self-assessments used in the rou-
tine care. In the analysis, CGI-I 1 or 2 was considered
improved and 3 or 4 was considered not improved.
The severity of depression was assessed by the treating
physician according to the International Classification of
Diagnosis 10th version (ICD) as mild/moderate, severe
without psychosis or severe with psychosis. A corre-
sponding severity classification was used in schizoaffec-
tive disorders, depressed type.
The outpatients were those with at least one ECT
administered in an outpatient setting. Thus if the treat-
ment was initiated in an inpatient setting and continued
in an outpatient setting the patient was considered to be
an outpatient in the statistical analysis.
The voluntary/involuntary hospital admission status
variable was based on the legal status of the patient. In
Sweden, verbal consent to ECT is standard and the
treating physician can administer ECT without consent
during involuntary care. Some voluntarily hospitalised
patients may recognise that they have to accept ECT or
else risk involuntary care. Some involuntarily hospita-
lised patients may consent to ECT.
Validation of measures
In 524 patients CGI-I improvement could be compared
to the pre to post ECT change in Global assessment of
functioning – symptoms score (GAF-S). Patients
improved according to CGI-I increased their GAF-S by
26 (SD 13) while those not improved increased their
GAF-S score by 8 (SD 8). In 80 patients pre to post ECT
change in Montgomery Åsberg Depression Rating Scale
(MADRS) was available. Improved patients decreasedMADRS by 26.6 (SD 12.5) and not improved by 6 (11.1).
Change in Montgomery Åsberg Depression Rating
Scale –Self Assessment (MADRS-SA) was available in
349 cases. Improved patients decreased MADRS-SA by
23.2 (SD 9.7) and not improved by 10.1 (SD 10.0). All
measures were recorded within one week before ECT
and within week after ECT. The nurses were trained to
assess Clinical Global Impression-Improvement, but the
inter-rater reliability was not investigated.
The severity classification according to ICD was com-
pared to the Clinical Global Impression –Severity (CGI-
S) score before ECT in 867 patients. CGI-S was assessed
by the physician who referred the patient for ECT. On
CGI-S patients classified as mild/moderately depressed
were scored 4.2 (SD 0.6), severe without psychosis 5.2
(SD 0.7) and severe with psychosis 5.7 (SD 0.6). GAF-S
scores before ECT was available in 601 cases. GAF-S
scores were, mild/moderately depressed patients 44
(SD 10), severe without psychosis 39 (SD 11), severe
with psychosis 33 (SD 11). MADRS scores amongst 151
patients before ECT were for mild/moderately depressed
30.3 (SD 8.6), severe depression without psychosis 34.0
(SD 6.8), severe depression with psychosis 36.4 (SD 7.9).
MADRS-S scores amongst 465 patients before ECT were
for mild/moderately depressed 31.7 (SD 7.9), for severely
depressed patients without psychosis 35.5 (SD 7.4)
and for patients with severe depression with psychosis
33.4 (SD 9.5).
Statistics
Frequency distributions were tested by means of chi-
square tests. Differences between means were tested by
the Student's t-test.
To assess the relative importance of certain factors, a
logistic regression, forward conditional, with improved
as dependent variable and factors with a trend toward
statistical significance in the univariate analysis entered
(p < 0.10).
The tests performed were two sided and alpha was set
to 0.05. SPSS version 15.0 (SPSS Inc, Chicago, Ill) was
used for the statistical analyses.
Results
Responder rate
Out of 936 patients, 750 were improved according to
CGI-I corresponding to an overall responder rate
of 80.1%.
Age, sex and diagnosis
A higher proportion of older patients (>50 years)
responded (84.3%) as compared to younger patients
(74.2%, p < 0.001). The responder rates were nearly
exactly the same in men and women. Patients with
severe, psychotic depressions had the highest responder
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psychotic depressions (81.5%) and patients with mild/
moderate depressions (72.8%), p < 0.001). However, the
responder rates were similar among patients suffering
from bipolar I, bipolar II, major depressive disorder,
single episode and major depressive disorder, recur-
rent depressions. There was a trend towards a lower
responder rate (68.8%, p = 0.060, df = 4) amongst patients
treated for a depressive episode of schizoaffective dis-
order. The lower responder rate amongst patients with
schizoaffective disorder, depressed type was statistically
significant in a post hoc comparison to all other patients
(χ2 = 4.1, p = 0.04, df = 1). Patients with co-morbid
anxiety disorders and dependence disorders had a
similar responder rate as compared to patients with-
out such diagnoses. Patients with personality disorders
had a lower responder rate (66.2%) as compared to
patients without co-morbid personality disorders (81.4%,
p = 0.001) (Table 1).
Treatment factors
Inpatients had an increased responder rate (83.4%) as
compared to outpatients (66.3%, p < 0.001). Also invol-
untarily admitted patients had higher responder rate
(87.5%) as compared to voluntarily (78.8%, p = 0.016)
admitted patients. Furthermore, there were no significantTable 1 Proportion of patients responding (CGI-I = 1 or 2) to E
Sex N= 936 Men (n = 399)
Women (n = 537)
Age (years) N = 936 Age < 50 years (n = 388)
Age ≥ 50 years (n = 548)
Diagnoses N= 936 Major depression, single e
Major depression, recurre
Bipolar I, depressed (n = 1
Bipolar II, depressed (n = 6
Schizoaffective disorder, d
Severity N = 917 Mild/moderate (n = 290)
Severe, non-psychotic (n =
Severe, psychotic (n = 226
Co-morbid Anxiety diagnosis N = 936 With co-morbid anxiety d
Without co-morbid anxie
Co-morbid Dependence diagnosis N = 936 With co-morbid depende
Without co-morbid depen
Co-morbid Personality disorder N = 936 With personality disorder
Without known personali
Out/in patient N = 936 Outpatient (n = 181)
Inpatient (n = 755)
Involuntary admission N= 936 Involuntary hospital admi
Voluntary hospital admissdifferences in responder rates whether unilateral ECT,
bifrontal ECT or bitemporal ECT was used, nor did the
dosage at the last ECT differ between responders and
non-responders (data not shown).
The number of ECT sessions were analysed in dif-
ferent subgroups. Older patients (>50 years) received
8.0 ECT (SD 3.0) and younger patients received 8.1
(SD 3.4). Mild/moderately depressed patients received
8.2 ECT (SD 3.3), severely depressed patient without
psychosis 8.0 (3.1) and severely depressed patients with
psychosis 7.8 ECT (SD 3.0). Patients treated for schizoaf-
fective disorder, depressed type received 8.7 ECT (SD
3.1) compared to other patients 8.0 (SD 3.2) (p = 0.17).
Patients with personality disorders received 8.6 ECT (SD
3.6) compared to 8.0 (3.1) for patients without personal-
ity disorder. Outpatients received 9.1 ECT (SD 4.1) and
inpatients 7.8 (SD 2.8), the difference was statistically
significant (p < 0.001).
Significant predictors
Older age, absence of schizoaffective disorder, psychotic
symptoms and inpatient status were independent sig-
nificant predictors of response in a forward conditional
logistic regression analysis. Improvement was the depend-
ent variable and age, diagnosis, severity of depression and
in/out patient status were independent variables.CT in relation to patient characteristics
79.7% χ2 = 0.08 p = 0.78
80.4%
74.2% χ2 = 14.5, p<0.001
84.3%
pisode (n = 149) 85.2% χ2 = 9.1 df, =4 p = 0.060
nt (n = 559) 81.0%
13) 77.9%
7) 73.1%
epressed (n = 48) 68.8%
72.8% χ2 = 21.7 df 2 p<0.001
401) 81.5%
) 88.9%
iagnosis (n = 254) 78.0% χ2 = 1.04, p = 0.31
ty diagnosis (n = 682) 80.9%
nce diagnosis (n = 102) 77.5% χ2 = 0.52, p = 0.47
dence diagnosis (n = 834) 80.5%
(n = 77) 66.2% χ2 = 10.2, p=0.001
ty disorder (n = 859) 81.4%
66.3% χ2 = 27.0, p<0.001
83.4%
ssion (n = 144) 87.5% χ2 = 5.81, p=0.016
ion (n = 792) 78.8%
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age in years (95% confidence interval 1.00-1.02). Patients
treated for schizoaffective disorder, depressed type had
a lower responder rate compared to patient treated
for recurrent major depressive disorder (95% confi-
dence interval of the odds-ratio 0.15-0.70). Mildly to
moderately depressed patients and severely depressed
patients had lower response rates compared to psych-
otically depressed patients (odds-ratios 0.22-0.63 and
0.30-0.89 respectively). As compared to inpatients, out-
patients had a lower response rate (odds-ratio 0.32-0.70)
(Table 2).
Discussion
Four out of five patients in a consecutive clinical sample
were improved by ECT similar to earlier reports from
clinical trials [3,4] and from clinical routine [5].
More severe forms of depression were associated with
higher proportion of responders to ECT, well in line
with earlier studies [6]. It is difficult to explain why some
earlier smaller studies have reported less positive out-
come in patients with psychotic depression [8,9]. How-
ever, the result from this study is robust and the
reported responder rate in psychotic depression is very
high. The Swedish National Health and Welfare Board
has given ECT the highest priority in patients with
severe forms of depression [17]. Our results are in line
with such a policy. The very high responder rate in
psychotic depression calls for early consideration of ECT
in such patients.
Older age was associated with a higher proportion of
responders to ECT. Our study provides further support
to earlier studies [7,10,12] indicating that older patients
benefit more than younger patients from ECT. In
addition, older patients may not tolerate the side effectsTable 2 Odds-ratio of response (CGI-I 1 or 2) in relation to ind
involuntary hospital admission status and in/out patient stat






Major depressive disorder, recurrent
Major depressive disorder, single episode
Bipolar I, depressive episode
Bipolar II, depressive episode
Schizoaffective disorder, depressive episodeof antidepressant drugs, especially not the anticholinergic
effects of tricyclics. Therefore, ECT should be considered
in geriatric depression.
Inpatient treatment was associated with a higher
responder rate than outpatient treatment. This effect
might be confounded by the severity of the disease. An
attempt was done to correct for severity of disease with
regression analysis. However, it is difficult to fully cor-
rect for severity as inpatients are so often more symp-
tomatic than outpatients. Especially some symptoms
such as psychosis, suicidal ideation and retardation may
be more prevalent among inpatients. Such symptoms
may be especially prone to respond to ECT. Outpatients
had longer treatment series than inpatients, thus the
difference could not be attributed to shorter treatment
series for outpatients. More intensive supportive care
may explain part of the difference. Also, inpatients are
more closely observed and it may be easier to adjust the
treatment according to the response.
The presence of a personality disorder has been
reported to be associated with a lower responder rate
after ECT [18] and other treatment modalities for depres-
sion [19]. It is a weakness of the study that no uniform
structured interview was used to diagnose personality dis-
orders and the condition may be unrecognised in clinical
practice. The data support a reasonably high responder
rate also amongst patients with apparent personality dis-
orders. Patients with personality disorders should there-
fore not automatically be disqualified from receiving ECT,
when suffering from psychotic or severe depression.
Patients treated for a depressive episode of a schizoaf-
fective disorder had a lower responder rate as compared
to patients with major depressive disorder and bipolar
disorder. This result is based on a limited number
of observations and is therefore somewhat uncertain.ependent variables: age, diagnosis, severity voluntary/
us (forward conditional logistic regression) n =917












Model chi square = 58.6, df = 8, p < 0.001
Nordenskjöld et al. BMC Psychiatry 2012, 12:115 Page 6 of 7
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population-based cohort and that the results reflect
current clinical routine use of ECT in Sweden.
Weaknesses include that some factors that have been
associated with response to ECT in earlier studies were
not recorded such as duration of depressive symptoms
in the episode and duration of pharmacologic treatment.
Therefore we cannot control for these factors. Also, the
presence of melancholic features was not recorded. The
CGI-I inter-rater reliability was not assessed. Moreover,
as CGI-I was performed by nurses involved with the
treatments, there is a risk of over-estimating the re-
sponse. The diagnoses were based on routine clinical
procedures. Thus, the diagnoses (e.g. major depressive
episode vs bipolar spectrum depression) should be con-
sidered clinical estimates as no uniform structured inter-
view was used.
This study focuses on the outcome immediately fol-
lowing ECT and is not informative of the longer term
outcome. Treatment response in this study is also not
equal to complete symptomatic remission. Many
patients have remaining symptoms after ECT that need
to be addressed even though they are significantly
improved. Thus, a high responder rate does not auto-
matically mean a high remission rate. We have reported
earlier that symptom reoccurrence is common soon after
ECT [20]. Further studies are needed to describe the
longer term outcome with ECT. We hope that the grow-
ing quality register will be able to contribute to that.Conclusions
Our results show that psychotically depressed patients
have a very high probability of benefit from ECT. We
further conclude that the responder rate to ECT tends
to be high for all groups investigated. Even in the least
responsive groups most patients responded to ECT. Fur-
thermore, inpatient ECT may be more effective than
outpatient ECT.
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